Association between intensive care unit-acquired dysglycemia and in-hospital mortality.
The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: Our objective was to quantify the association between intensive care unit-acquired dysglycemia (hyperglycemia, hypoglycemia, and high variability) and in-hospital mortality. DESIGN: Retrospective, observational study. SETTING: eICU Research Institute participating hospitals with an active tele-ICU program between January 1, 2008, and September 30, 2010, representing 784,392 adult intensive care unit patients. PATIENTS: A total of 194,772 patients met inclusion criteria with an intensive care unit length of stay >48 hrs. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: Acute Physiology and Chronic Health Evaluation IV standardized mortality ratios were calculated for dysglycemia present at admission and acquired in the intensive care unit. Intensive care unit-acquired dysglycemia was modeled using multivariable modified Poisson regression to account for confounding not incorporated in Acute Physiology and Chronic Health Evaluation. Dysglycemia severity was assessed by the relative risk of in-hospital mortality associated with the maximum, time-weighted average daily glucose; lowest glucose value throughout the intensive care unit stay; and quintiles of variability (coefficient of variation). The association of duration beyond thresholds of dysglycemia on mortality was also modeled. The adjusted relative risk (95% confidence interval) of mortality for the maximum intensive care unit average daily glucose was 1.13 (1.04-1.58), 1.43 (1.30-1.58), 1.63 (1.47-1.81), 1.76 (1.55-1.99), and 1.89 (1.62-2.19) for 110-150 mg/dL, 151-180 mg/dL, 180-240 mg/dL, 240-300 mg/dL, and >300 mg/dL, respectively, compared to patients whose highest average daily glucose was 80-110 mg/dL. The relative risk of mortality for the lowest glucose value was 1.67 (1.37-2.03), 1.53 (1.37-1.70), 1.12 (1.04-1.21), and 1.06 (1.01-1.11) for <20 mg/dL, 20-40 mg/dL, 40-60 mg/dL, and 60-80 mg/dL, respectively, compared to patients whose lowest value was 80-110 mg/dL. The relative risk of mortality increased with greater duration of hyperglycemia and with increased variability. The relative risk for the highest compared to lowest quintile of variability was 1.61 (1.47-1.78). The association of duration of hyperglycemia on mortality was more pronounced with more severe hyperglycemia. CONCLUSIONS: The risk of mortality progressively increased with severity and duration of deviation from euglycemia and with increased variability. These data suggest that severe intensive care unit-acquired hyperglycemia, hypoglycemia, and variability are associated with similar risks of mortality.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These studies showed differing results, which may have been caused by differences in airway pressures in the treatment and control groups (423, 424, 428).”
From Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021. (2021) · cites this paper as [428]
In the citing paper
“Hyperglycemia (> 180 mg/dL), hypoglycemia and increased glycemic variability are associated with increased mortality in critically ill patients [509–511].”
From Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 (2021) · cites this paper as [509]
Citations
Cites
Intensive insulin therapy in critically ill patients.
Van den Berghe, G., Wouters, P., Weekers, F., Verwaest, C., Bruyninckx, F., Schetz, M., Vlasselaers, D., Ferdinande, P., Lauwers, P., & Bouillon, R. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011300 · Cited by 9,977
A Modified Poisson Regression Approach to Prospective Studies with Binary Data
Zou, G. (2004) · American Journal of Epidemiology · doi:10.1093/aje/kwh090 · Cited by 9,615
Intensive versus Conventional Glucose Control in Critically Ill Patients
(2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810625 · Cited by 5,119
Intensive insulin therapy in the medical ICU
Van den Berghe, G., Wilmer, A., Hermans, G., Meersseman, W., Wouters, P. J., Milants, I., Van Wijngaerden, E., Bobbaers, H., & Bouillon, R. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052521 · Cited by 3,639 · cited 2×
“Normoglycaemia in Intensive Care Evaluation and Survival Using Glucose Algorithm Regulation (NICE–SUGAR) and other randomized-controlled trials of TGC strategies have demonstrated that targeting TGC does not generally improve outcomes in critically ill patients, but maintaining glycemic control within the target range…”
BackgroundMethodKrinsley, J. S. (2003) · Mayo Clinic Proceedings · doi:10.4065/78.12.1471 · Cited by 1,165
Griesdale, D. E. G., de Souza, R. J., van Dam, R. M., Heyland, D. K., Cook, D. J., Malhotra, A., Dhaliwal, R., Henderson, W. R., Chittock, D. R., Finfer, S., et al. (2009) · Canadian Medical Association Journal · doi:10.1503/cmaj.090206 · Cited by 1,096
Glucose Control and Mortality in Critically Ill Patients
Finney, S. J. (2003) · JAMA · doi:10.1001/jama.290.15.2041 · Cited by 1,055
Inappropriate use of bivariable analysis to screen risk factors for use in multivariable analysis
Sun, G.-W., Shook, T. L., & Kay, G. L. (1996) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(96)00025-x · Cited by 933 · cited 1×
“Due to the questionable value of bivariable analysis as variable selection criteria, bivariate statistical significance tests were not used to guide inclusion of covariates in the model (27).”
MethodVariability of Blood Glucose Concentration and Short-term Mortality in Critically Ill Patients
Egi, M., Bellomo, R., Stachowski, E., French, C. J., & Hart, G. (2006) · Anesthesiology · doi:10.1097/00000542-200608000-00006 · Cited by 854
Glycemic variability: A strong independent predictor of mortality in critically ill patients.
Krinsley, J. S. (2008) · Critical Care Medicine · doi:10.1097/ccm.0b013e31818b38d2 · Cited by 729
Severe hypoglycemia in critically ill patients: risk factors and outcomes
Krinsley, J. S., & Grover, A. (2007) · Critical Care Medicine · doi:10.1097/01.ccm.0000282073.98414.4b · Cited by 671 · cited 1×
“Further detail regarding the structure and process of the eRI are presented elsewhere (17).”
BackgroundThe metrics of glycaemic control in critical care
Mackenzie, I. M. J., Whitehouse, T., & Nightingale, P. (2011) · Intensive Care Medicine · doi:10.1007/s00134-010-2103-2 · Cited by 594 · cited 1×
“It is well-known that hypoglycemia, hyperglycemia, and increased glucose variability are all detrimental to critically ill patients, but studies quantifying their relative adverse effects to one another are few (9, 10).”
BackgroundHyperglycemia-related mortality in critically ill patients varies with admission diagnosis
Falciglia, M., Freyberg, R. W., Almenoff, P. L., D’Alessio, D. A., & Render, M. L. (2009) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181b083f7 · Cited by 576 · cited 2×
“We also did not systematically evaluate the potential interaction that admission diagnosis had on the effect of glycemic control and mortality, although this issue was comprehensively analyzed by Falciglia et al (12).”
BackgroundMoghissi, E. S., Korytkowski, M. T., DiNardo, M., Einhorn, D., Hellman, R., Hirsch, I. B., Inzucchi, S. E., Ismail-Beigi, F., Kirkman, M. S., & Umpierrez, G. E. (2009) · Endocrine Practice · doi:10.4158/ep09102.ra · Cited by 518 · cited 1×
“12 hypoglycemia and that protocols should target glucose concentrations >140 mg/ dL to ensure hypoglycemia never occurs (6, 29).”
BackgroundGlucose variability is associated with intensive care unit mortality*
Hermanides, J., Vriesendorp, T. M., Bosman, R. J., Zandstra, D. F., Hoekstra, J. B., & DeVries, J. H. (2010) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181cc4be9 · Cited by 437
Hypoglycemia and outcome in critically ill patients
Egi, M., Bellomo, R., Stachowski, E., French, C. J., Hart, G. K., Taori, G., Hegarty, C., & Bailey, M. (2010) · Mayo Clinic Proceedings · doi:10.4065/mcp.2009.0394 · Cited by 432 · cited 1×
“Another limitation is that we did not adjust for glycemic control treatments or management strategies although prior literature suggests that insulin is not an independent predictor of mortality after accounting for glycemic control (16, 31).”
BackgroundGlucose variability and mortality in patients with sepsis*
Ali, N. A., OʼBrien, J. M., Dungan, K., Phillips, G., Marsh, C. B., Lemeshow, S., Connors, A. F., & Preiser, J.-C. (2008) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181810378 · Cited by 432
Blood glucose concentration and outcome of critical illness: The impact of diabetes*
Egi, M., Bellomo, R., Stachowski, E., French, C. J., Hart, G. K., Hegarty, C., & Bailey, M. (2008) · Critical Care Medicine · doi:10.1097/ccm.0b013e318181039a · Cited by 399
Qaseem, A., Humphrey, L. L., Chou, R., Snow, V., Shekelle, P., & for the Clinical Guidelines Committee of the American College of Physicians* (2011) · Annals of Internal Medicine · doi:10.7326/0003-4819-154-4-201102150-00007 · Cited by 334
The Impact of Early Hypoglycemia and Blood Glucose Variability on Outcome in Critical Illness
Bagshaw, S. M., Bellomo, R., Jacka, M. J., Egi, M., Hart, G. K., George, C., & the ANZICS CORE Management Committee (2009) · Critical Care · doi:10.1186/cc7921 · Cited by 285
Hypoglycemia is associated with intensive care unit mortality*
Hermanides, J., Bosman, R. J., Vriesendorp, T. M., Dotsch, R., Rosendaal, F. R., Zandstra, D. F., Hoekstra, J. B. L., & DeVries, J. H. (2010) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181de562c · Cited by 236
Kavanagh, B. P., & McCowen, K. C. (2010) · New England Journal of Medicine · doi:10.1056/nejmcp1001115 · Cited by 205 · cited 1×
“1 mmol/L), many ICUs adopted this strategy (2).”
BackgroundBenefits and Risks of Tight Glucose Control in Critically Ill Adults: A Meta-analysis
Wiener, R. S., Wiener, D. C., & Larson, R. J. (2008) · JAMA · doi:10.1001/jama.300.8.933 · Cited by 200
Meyfroidt, G., Keenan, D. M., Wang, X., Wouters, P. J., Veldhuis, J. D., & Van den Berghe, G. (2010) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181cf710e · Cited by 196 · cited 1×
“It is well-known that hypoglycemia, hyperglycemia, and increased glucose variability are all detrimental to critically ill patients, but studies quantifying their relative adverse effects to one another are few (9, 10).”
BackgroundGlycemic Variability and Mortality in Critically 111 Patients: The Impact of Diabetes
Krinsley, J. S. (2009) · Journal of Diabetes Science and Technology · doi:10.1177/193229680900300609 · Cited by 192
Early blood glucose control and mortality in critically ill patients in Australia*
Bagshaw, S. M., Egi, M., George, C., & Bellomo, R. (2009) · Critical Care Medicine · doi:10.1097/ccm.0b013e318194b097 · Cited by 167
Lilly, C. M., Zuckerman, I. H., Badawi, O., & Riker, R. R. (2011) · CHEST Journal · doi:10.1378/chest.11-0718 · Cited by 132
Self-citationThe eICU Research Institute - A Collaboration Between Industry, Health-Care Providers, and Academia
McShea, M., Holl, R., Badawi, O., Riker, R., & Silfen, E. (2010) · IEEE Engineering in Medicine and Biology Magazine · doi:10.1109/memb.2009.935720 · Cited by 65 · cited 1×
“Additional details regarding the structure and process of the eICU Research Institute are presented elsewhere (25, 26).”
MethodSelf-citationEvaluation of Glycemic Control Metrics for Intensive Care Unit Populations
Badawi, O., Yeung, S. Y. A., & Rosenfeld, B. A. (2009) · American Journal of Medical Quality · doi:10.1177/1062860609336366 · Cited by 28 · cited 3×
“Our definition of hyperglycemia used a daily, time-weighted average glucose, which represents exposure to hyperglycemia more accurately than a single value (8).”
BackgroundMethodSelf-citation
Cited by
Surviving Sepsis Campaign: International guidelines for management of sepsis and septic shock: 2016.
Rhodes, A., Evans, L. E., Alhazzani, W., Levy, M. M., Antonelli, M., Ferrer, R., Kumar, A., Sevransky, J. E., Sprung, C. L., Nunnally, M. E., et al. (2017) · Intensive Care Medicine · doi:10.1007/s00134-017-4683-6 · Cited by 6,621
Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021
Evans, L., Rhodes, A., Alhazzani, W., Antonelli, M., Coopersmith, C. M., French, C., Machado, F. R., Mcintyre, L., Ostermann, M., Prescott, H. C., et al. (2021) · Intensive Care Medicine · doi:10.1007/s00134-021-06506-y · Cited by 5,082
Surviving Sepsis Campaign: International guidelines for management of sepsis and septic shock: 2016.
Rhodes, A., Evans, L. E., Alhazzani, W., Levy, M. M., Antonelli, M., Ferrer, R., Kumar, A., Sevransky, J. E., Sprung, C. L., Nunnally, M. E., et al. (2017) · Critical Care Medicine · doi:10.1097/ccm.0000000000002255 · Cited by 3,652
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021.
Evans, L., Rhodes, A., Alhazzani, W., Antonelli, M., Coopersmith, C. M., French, C., Machado, F. R., Mcintyre, L., Ostermann, M., Prescott, H. C., et al. (2021) · Critical Care Medicine · doi:10.1097/ccm.0000000000005337 · Cited by 2,935
Stress hyperglycemia: an essential survival response!
Marik, P. E., & Bellomo, R. (2013) · Critical Care · doi:10.1186/cc12514 · Cited by 729
Metadata
- Authors
- Badawi, O., Waite, M. D., Fuhrman, S. A., & Zuckerman, I. H.
- Affiliations
- University of Maryland, Baltimore (US)
- ORCID
- Badawi, Omar
- Venue
- Critical Care Medicine
- Published
- 2012-12
- Volume
- 40
- Issue
- 12
- Pages
- 3180-3188
- ISSN
- 0090-3493 (ISSN-L)
- OpenAlex
- W1974957474
- Cited by
- 142
- References
- 29
- Citations by year
- 2026: 4 · 2025: 6 · 2024: 9 · 2023: 13 · 2022: 10 · 2021: 11 · 2020: 10 · 2019: 8 · 2018: 15 · 2017: 11 · 2016: 13 · 2015: 14 · 2014: 11 · 2013: 6 · 2012: 1
- FWCI
- 8.20
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Critical Care Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Intensive Care Unit Cognitive Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- hyperglycemia, hypoglycemia, glycemic variability, in-hospital mortality, critically ill patients, tele-ICU, glucose threshold, mortality risk stratification, ICU length of stay, sepsis, mechanical ventilation
- MeSH terms
- Aged, Aged, 80 and over, Blood Glucose, Female, Humans, Hyperglycemia, Hypoglycemia, Intensive Care Units, Male, Middle Aged, Retrospective Studies, United States, Baltimore, Cohort Studies, Hospital Mortality, Qualitative Research
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.